MiRXES Pte
Latest round
- Series D
Last raised
- Jul 2023
Total raised
- $257M
Investors
- 15
About MiRXES Pte
Based in Singapore, and established in 2014, MiRXES Pte Ltd is a biotechnology company that provides the early diagnostic detection of cancer and other diseases. It spun off from Agency of Science, Technology and Research. It has additaionals offices in China, Hong Kong, Japan, and USA. In 2015, it launched ID3EAL suite of miRNA discovery tools. In 2016, it established production bases of in vitro diagnostic in Singapore. In 2018, it established joint R&D labs with Beth Israel, Deaconess Medical Center, Boston, USA, and the National University of Singapore. In 2020, it provides COVIND-19 PCR test kit and sold to 45 countries. The company provides GASTROClear for the early detection of gastric cancer, microRNA-based blood test. It has technology platforms, including ID3EAL Suite, and ID3EAL panoramiR miRNA knowledge panel. It also provides solutions, which can be divided into genomics, cancer screening, cancer treatment selection, and infectious diseases. The genomics solutions include clinical sequencing, and research sequencing.1, fortitude syndromic panel, swab & saliva collection, and RNA extraction kits & instruments. It also plans to list on Hong Kong Stock Exchange.
Who invested in MiRXES Pte
15 investors across 5 rounds
See all investors in MiRXES Pte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MiRXES Pte
Who invested in MiRXES Pte?
MiRXES Pte has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MiRXES Pte raised?
MiRXES Pte has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did MiRXES Pte last raise money?
MiRXES Pte's most recent round on record is a Series D, in Jul 2023.
What does MiRXES Pte do?
Based in Singapore, and established in 2014, MiRXES Pte Ltd is a biotechnology company that provides the early diagnostic detection of cancer and other diseases.
Where is MiRXES Pte headquartered?
MiRXES Pte is headquartered in Singapore, Singapore.
Which VCs invest in companies like MiRXES Pte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MiRXES Pte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like MiRXES Pte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.